21 children with megaloblastic anemia in the above said period was studied. The patient's age ranged from 2 mo- 15 years. There was a bimodal distribution with 66.6% of patients being between 2months -3 years and 33% being in the age group of 13- 15 years. There were no patients in age group between 3years - 13 years. Megaloblastic anemia was more common in female children with the ratio being 1.6:1 in favor of females. The commonest symptoms were pallor (61.9%), fatigue (47.6%) and neurological involvement (33%.The frequency of symptoms and signs are as listed in tables 1 and 2 respectively.
| Symptoms |
No of patients (%) |
| Pallor |
13 (61.9%) |
| Fatigue |
10 (47.6%) |
| Neurological |
7 (33%) |
| Jaundice |
5 (23.8%) |
| Bleeding manifestations |
3 (14.3%) |
| Recurrent fever |
2(9.5%) |
| Weight loss/ failure to gain weight |
6(28.6%) |
Table 1 -Frequency of symptoms
| SIGNS |
No of patients (%) |
| Wasting/ failure to thrive |
13 (61.9%) |
| Pallor |
20 (95.2%) |
| Skin hyperpigmentation |
12 (57.1%) |
| Hepatomegaly |
17(81%) |
| Neurologicalsigns (apathy/developmental delay/regression/hypotonia) |
7(33.3%) |
| Splenomegaly |
5(23.8%) |
Table 2: Frequency of signs
| Investigations |
Mean ± SD |
| Hemoglobin (g%) |
6.195 ± 2.54 |
| MCV (fl) |
98.47 ±10.14 |
| MCH |
34.04 ± 4.67 |
| MCHC |
34.72 ± 3.31 |
| Corrected reticulocyte count (%) |
1.5 ± 2.3 |
| Leukocyte count(/cu mm) |
5,880 ± 2904 |
| > Neutrophil count (/cu mm) |
1299 ± 922.7 |
| Platelet count /cmm |
98,833 ± 56,839 |
Table 3: Hematological profile
The number of patients who had severe anemia (Hb<7g%) was 14 (66.6%). The lowest hemoglobin noted was 2.7g%. 2 patients (9.5%) had hemoglobin which was normal but these were patients who had received blood transfusions and 6 patients (28.5%) had MCV which was normal. About 66% of patients had low corrected reticulocyte count.
Pancytopenia was seen in 23.8% of patients. Bicytopenia was seen in 23.8% of the patients. 23.8%of patients had leucopenia. A significant number of patients had neutropenia (66.7%).
Macrocytosis was found in 81% of peripheral smears and bone marrow confirmed Megaloblastic anemia in 92.99%. Vitamin B 12 assay which was done in 8 patients showed low levels (<100pg/ml).
On multivariate analysis neurological involvement correlated significantly with age (P value 0.018%) and symptoms of fatigue (P value 0.012) and fatigue correlated significantly with low Vitamin B 12 levels (P value 0.01) and MCHC (P value 0.011)
Resolution of anemia was seen with treatment in 10 patients who subsequently followed up (47.6%).The mean time taken for resolution of anemia was 42.5 days. There was resolution of the neurological signs, most importantly apathy in all the 7 patients who had neurological signs.